ATE219149T1 - Verfahren zur bestimmung von crohn's krankheit und colitis ulcerosa - Google Patents

Verfahren zur bestimmung von crohn's krankheit und colitis ulcerosa

Info

Publication number
ATE219149T1
ATE219149T1 AT96908202T AT96908202T ATE219149T1 AT E219149 T1 ATE219149 T1 AT E219149T1 AT 96908202 T AT96908202 T AT 96908202T AT 96908202 T AT96908202 T AT 96908202T AT E219149 T1 ATE219149 T1 AT E219149T1
Authority
AT
Austria
Prior art keywords
crohn
disease
colitis
ulcerosal
determining
Prior art date
Application number
AT96908202T
Other languages
English (en)
Inventor
Andrew Jeremy Wakefield
Original Assignee
Andrew Jeremy Wakefield
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andrew Jeremy Wakefield filed Critical Andrew Jeremy Wakefield
Application granted granted Critical
Publication of ATE219149T1 publication Critical patent/ATE219149T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/165—Mumps or measles virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6865—Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement Of Velocity Or Position Using Acoustic Or Ultrasonic Waves (AREA)
  • Electrotherapy Devices (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT96908202T 1995-03-28 1996-03-22 Verfahren zur bestimmung von crohn's krankheit und colitis ulcerosa ATE219149T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9506298.0A GB9506298D0 (en) 1995-03-28 1995-03-28 Diagnostic system
PCT/GB1996/000706 WO1996030544A1 (en) 1995-03-28 1996-03-22 Diagnostic and therapeutic system for crohn's disease and colitia ulcerosa

Publications (1)

Publication Number Publication Date
ATE219149T1 true ATE219149T1 (de) 2002-06-15

Family

ID=10772018

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96908202T ATE219149T1 (de) 1995-03-28 1996-03-22 Verfahren zur bestimmung von crohn's krankheit und colitis ulcerosa

Country Status (10)

Country Link
US (1) US6309819B1 (de)
EP (1) EP0817864B1 (de)
JP (1) JPH11502707A (de)
AT (1) ATE219149T1 (de)
AU (1) AU701316B2 (de)
CA (1) CA2216807A1 (de)
DE (1) DE69621791D1 (de)
GB (2) GB9506298D0 (de)
HK (1) HK1002983A1 (de)
WO (1) WO1996030544A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7780598A (en) * 1997-06-05 1998-12-21 Neuroimmuno Therapeutics Research Foundation Pharmaceutical composition containing transfer factor for treatment of inflam matory bowel disease and regressive behavioural disorder
GB2347742B (en) * 1997-06-05 2001-11-07 Royal Free Hosp School Med Pharmaceutical composition for RBD
GB9717972D0 (en) * 1997-08-22 1997-10-29 Amersham Int Ltd Labelling composition and method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871759A (en) 1973-06-18 1989-10-03 Mercer James B Method of treatment of mesenteric adenitis

Also Published As

Publication number Publication date
EP0817864A1 (de) 1998-01-14
JPH11502707A (ja) 1999-03-09
CA2216807A1 (en) 1996-10-03
US6309819B1 (en) 2001-10-30
WO1996030544A1 (en) 1996-10-03
GB2300259B (en) 1999-06-23
DE69621791D1 (de) 2002-07-18
GB9506298D0 (en) 1995-05-17
HK1002983A1 (en) 1998-09-30
AU701316B2 (en) 1999-01-28
EP0817864B1 (de) 2002-06-12
AU5153196A (en) 1996-10-16
GB9606038D0 (en) 1996-05-22
GB2300259A (en) 1996-10-30

Similar Documents

Publication Publication Date Title
CN100441700C (zh) 有效检测丙型肝炎病毒(hcv)的寡核苷酸引物及其应用方法
Gottlieb et al. Studies on macrophage RNA involved in antibody production.
Klimstra et al. The furin protease cleavage recognition sequence of Sindbis virus PE2 can mediate virion attachment to cell surface heparan sulfate
Chou Differentiation of cytomegalovirus strains by restriction analysis of DNA sequences amplified from clinical specimens
Vey et al. Proteolytic processing of human cytomegalovirus glycoprotein B (gpUL55) is mediatedby the human endoprotease furin
DE69332642T2 (de) Methoden zur detektion von mikrometastasen bei prostata-krebs
Dhar et al. Nucleotide sequence of the DNA replication origin for human papovavirus BKV: sequence and structural homology with SV40
TR199800613A1 (xx) Nezle A��s�.
HU9300398D0 (en) Oligo-nucleotides influencing effect of infection by cyto-megalo virus
ES2013346A6 (es) Metodos para producir secuencias y moleculas de adn recombinante, asi como proteinas t4 solubles.
ATE419368T1 (de) System zum transfer und zur expression von heterologen genen ins knochenmark in vivo
ATE121794T1 (de) Verfahren zum nachweis des karzinogenen menschlichen papillomavirus.
Hayashi et al. Elucidation of a conserved RNA stem-loop structure in the packaging signal of human immunodeficiency virus type 1
ZA200102182B (en) Identification of microorganisms causing acute respiratory tract infections (ARI).
Tooker et al. Semliki Forest virus multiplication in clones of Aedes albopictus cells
Reis et al. Recombinant envelope protein (rgp90) ELISA for equine infectious anemia virus provides comparable results to the agar gel immunodiffusion
HUP9901005A2 (hu) Herpeszvírusok RFHV/KSHV-alcsaládjába tartozó vírusokból származó glikoprotein-B
ATE219149T1 (de) Verfahren zur bestimmung von crohn's krankheit und colitis ulcerosa
WO1996040764A3 (en) Nucleotide and amino acid sequences of hypervariable region 1 of the envelope 2 gene of hepatitis c virus
Zampino et al. Hepatitis G virus/GBV‐C persistence: absence of hypervariable E2 region and genetic analysis of viral quasispecies in serum and lymphocytes
Polyak et al. Comparison of amplification enzymes for hepatitis C virus quasispecies analysis
HUP0200320A2 (hu) Macskaeredetű CD28-at, CD80-at, CD86-ot vagy CTL4-A-t expresszáló rekombináns vírusok és alkalmazásuk
WO2003023027A3 (de) Tt-virus-sequenzen in menschlichen tumorgeweben, mittel zu deren nachweis sowie tumortherapie
MIZUTANI et al. Inhibition of mouse hepatitis virus multiplication by an oligonucleotide complementary to the leader RNA
FI973762A0 (fi) Ny gen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties